nach oben

Tumor Biology

Erschienen in:

01.09.2014 | Research Article

TRPM8 promotes aggressiveness of breast cancer cells by regulating EMT via activating AKT/GSK-3β pathway

verfasst von: Jinxin Liu, Yizhi Chen, Shuai Shuai, Dapeng Ding, Rong Li, Rongcheng Luo

Erschienen in: Tumor Biology | Ausgabe 9/2014

Einloggen, um Zugang zu erhalten

Abstract

Breast cancer already taken the first place of incidence in Chinese female cancer patients. TRPM8 is found to be over-expressed in breast cancer, but whether it promotes breast cancer aggressiveness remains unknown. In our study, TRPM8 was identified highly expressing in all the tested breast cancer cell lines including MCF-7, T47D, MDA-MB-231, BT549, SKBR3 and ZR-75-30, while it just could be detected in MCF-10A, the normal breast epithelial cell. Then four pairs of clinical samples were analyzed using Western blotting and the result showed that TRPM8 expression is higher in tumor tissues than in adjacent nontumor tissues. Subsequently, we established TRPM8 high-expressing MCF-7 cell line and TRPM8 knockout MDA-MB-231 cell line to explore expression status of cancer-related proteins. The Western blotting and immunofluorescence analysis outcomes demonstrated that TRPM8 might influence cancer cell metastasis by regulating the EMT phenotype via activating AKT/GSK-3β pathway, and the hypothesis had been supported by cell function tests. All the results demonstrated that TRPM8 significantly up-expressed in breast cancer cells and promoted their metastasis by regulating EMT via activating AKT/GSK-3β pathway, indicating TRPM8 gets the prospects of to be developed as medication or diagnostic indicator to be applied in clinical work.

Cuzick J, Sestak I, Bonanni B, Costantino JP, Cummings S, DeCensi A, et al. Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data. Lancet. 2013;381(9880):1827–34. doi:10.1016/S0140-6736(13)60140-3.PubMedCentralPubMedCrossRef

Engebraaten O, Vollan HK, Borresen-Dale AL. Triple-negative breast cancer and the need for new therapeutic targets. Am J Pathol. 2013. doi:10.1016/j.ajpath.2013.05.033.PubMed

Lee GS, Jeung EB. Uterine TRPV6 expression during the estrous cycle and pregnancy in a mouse model. Am J Physiol Endocrinol Metab. 2007;293(1):E132–8. doi:10.1152/ajpendo.00666.2006.PubMedCrossRef

Bolanz KA, Hediger MA, Landowski CP. The role of TRPV6 in breast carcinogenesis. Mol Cancer Ther. 2008;7(2):271–9. doi:10.1158/1535-7163.MCT-07-0478.PubMedCrossRef

Nilius B. TRP channels in disease. Biochim Biophys Acta. 2007;1772(8):805–12. doi:10.1016/j.bbadis.2007.02.002.PubMedCrossRef

Gkika D, Prevarskaya N. Molecular mechanisms of TRP regulation in tumor growth and metastasis. Biochim Biophys Acta. 2009;1793(6):953–8. doi:10.1016/j.bbamcr.2008.11.010.PubMedCrossRef

Prevarskaya N, Zhang L, Barritt G. TRP channels in cancer. Biochim Biophys Acta. 2007;1772(8):937–46. doi:10.1016/j.bbadis.2007.05.006.PubMedCrossRef

McKemy DD, Neuhausser WM, Julius D. Identification of a cold receptor reveals a general role for TRP channels in thermosensation. Nature. 2002;416(6876):52–8. doi:10.1038/nature719.PubMedCrossRef

Peier AM, Moqrich A, Hergarden AC, Reeve AJ, Andersson DA, Story GM, et al. A TRP channel that senses cold stimuli and menthol. Cell. 2002;108(5):705–15.PubMedCrossRef

10.

Harrington AM, Hughes PA, Martin CM, Yang J, Castro J, Isaacs NJ, et al. A novel role for TRPM8 in visceral afferent function. Pain. 2011;152(7):1459–68. doi:10.1016/j.pain.2011.01.027.PubMedCrossRef

11.

Brignell JL, Chapman V, Kendall DA. Comparison of icilin- and cold-evoked responses of spinal neurones, and their modulation of mechanical activity, in a model of neuropathic pain. Brain Res. 2008;1215:87–96. doi:10.1016/j.brainres.2008.03.072.PubMedCrossRef

12.

Proudfoot CJ, Garry EM, Cottrell DF, Rosie R, Anderson H, Robertson DC, et al. Analgesia mediated by the TRPM8 cold receptor in chronic neuropathic pain. Curr Biol CB. 2006;16(16):1591–605. doi:10.1016/j.cub.2006.07.061.PubMedCrossRef

13.

Knowlton WM, Daniels RL, Palkar R, McCoy DD, McKemy DD. Pharmacological blockade of TRPM8 ion channels alters cold and cold pain responses in mice. PLoS One. 2011;6(9):e25894. doi:10.1371/journal.pone.0025894.PubMedCentralPubMedCrossRef

14.

Tsavaler L, Shapero MH, Morkowski S, Laus R. Trp-p8, a novel prostate-specific gene, is up-regulated in prostate cancer and other malignancies and shares high homology with transient receptor potential calcium channel proteins. Cancer Res. 2001;61(9):3760–9.PubMed

15.

Chodon D, Guilbert A, Dhennin-Duthille I, Gautier M, Telliez MS, Sevestre H, et al. Estrogen regulation of TRPM8 expression in breast cancer cells. BMC Cancer. 2010;10:212. doi:10.1186/1471-2407-10-212.PubMedCentralPubMedCrossRef

16.

Ouadid-Ahidouch H, Dhennin-Duthille I, Gautier M, Sevestre H, Ahidouch A. TRP calcium channel and breast cancer: expression, role and correlation with clinical parameters. Bull Cancer. 2012;99(6):655–64. doi:10.1684/bdc.2012.1595.PubMed

17.

Dhennin-Duthille I, Gautier M, Faouzi M, Guilbert A, Brevet M, Vaudry D, et al. High expression of transient receptor potential channels in human breast cancer epithelial cells and tissues: correlation with pathological parameters. Cell Physiol Biochem Int J Exp Cell Physiol Biochem Pharmacol. 2011;28(5):813–22. doi:10.1159/000335795.CrossRef

18.

Malkia A, Morenilla-Palao C, Viana F. The emerging pharmacology of TRPM8 channels: hidden therapeutic potential underneath a cold surface. Curr Pharm Biotechnol. 2011;12(1):54–67.PubMedCrossRef

19.

Voulgari A, Pintzas A. Epithelial–mesenchymal transition in cancer metastasis: mechanisms, markers and strategies to overcome drug resistance in the clinic. Biochim Biophys Acta. 2009;1796(2):75–90. doi:10.1016/j.bbcan.2009.03.002.PubMed

20.

Taylor MA, Parvani JG, Schiemann WP. The pathophysiology of epithelial–mesenchymal transition induced by transforming growth factor-beta in normal and malignant mammary epithelial cells. J Mammary Gland Biol Neoplasia. 2010;15(2):169–90. doi:10.1007/s10911-010-9181-1.PubMedCentralPubMedCrossRef

21.

Radisky ES, Radisky DC. Matrix metalloproteinase-induced epithelial–mesenchymal transition in breast cancer. J Mammary Gland Biol Neoplasia. 2010;15(2):201–12. doi:10.1007/s10911-010-9177-x.PubMedCentralPubMedCrossRef

22.

Jin H, Morohashi S, Sato F, Kudo Y, Akasaka H, Tsutsumi S, et al. Vimentin expression of esophageal squamous cell carcinoma and its aggressive potential for lymph node metastasis. Biomed Res. 2010;31(2):105–12.PubMedCrossRef

23.

Cai Z, Wang Q, Zhou Y, Zheng L, Chiu JF, He QY. Epidermal growth factor-induced epithelial–mesenchymal transition in human esophageal carcinoma cells—a model for the study of metastasis. Cancer Lett. 2010;296(1):88–95. doi:10.1016/j.canlet.2010.03.020.PubMedCrossRef

24.

Larue L, Bellacosa A. Epithelial–mesenchymal transition in development and cancer: role of phosphatidylinositol 3′ kinase/AKT pathways. Oncogene. 2005;24(50):7443–54. doi:10.1038/sj.onc.1209091.PubMedCrossRef

25.

Bakin AV, Tomlinson AK, Bhowmick NA, Moses HL, Arteaga CL. Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration. J Biol Chem. 2000;275(47):36803–10. doi:10.1074/jbc.M005912200.PubMedCrossRef

26.

Grille SJ, Bellacosa A, Upson J, Klein-Szanto AJ, van Roy F, Lee-Kwon W, et al. The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines. Cancer Res. 2003;63(9):2172–8.PubMed

27.

Julien S, Puig I, Caretti E, Bonaventure J, Nelles L, van Roy F, et al. Activation of NF-kappaB by Akt upregulates Snail expression and induces epithelium mesenchyme transition. Oncogene. 2007;26(53):7445–56. doi:10.1038/sj.onc.1210546.PubMedCrossRef

28.

Wang H, Quah SY, Dong JM, Manser E, Tang JP, Zeng Q. PRL-3 down-regulates PTEN expression and signals through PI3K to promote epithelial–mesenchymal transition. Cancer Res. 2007;67(7):2922–6. doi:10.1158/0008-5472.CAN-06-3598.PubMedCrossRef

29.

Thiery JP, Sleeman JP. Complex networks orchestrate epithelial–mesenchymal transitions. Nat Rev Mol Cell Biol. 2006;7(2):131–42. doi:10.1038/nrm1835.PubMedCrossRef

30.

Huber MA, Kraut N, Beug H. Molecular requirements for epithelial–mesenchymal transition during tumor progression. Curr Opin Cell Biol. 2005;17(5):548–58. doi:10.1016/j.ceb.2005.08.001.PubMedCrossRef

31.

Mo YY, Beck WT. Association of human DNA topoisomerase IIalpha with mitotic chromosomes in mammalian cells is independent of its catalytic activity. Exp Cell Res. 1999;252(1):50–62. doi:10.1006/excr.1999.4616.PubMedCrossRef

32.

Rieger-Christ KM, Lee P, Zagha R, Kosakowski M, Moinzadeh A, Stoffel J, et al. Novel expression of N-cadherin elicits in vitro bladder cell invasion via the Akt signaling pathway. Oncogene. 2004;23(27):4745–53. doi:10.1038/sj.onc.1207629.PubMedCrossRef

33.

Song LB, Zeng MS, Liao WT, Zhang L, Mo HY, Liu WL, et al. Bmi-1 is a novel molecular marker of nasopharyngeal carcinoma progression and immortalizes primary human nasopharyngeal epithelial cells. Cancer Res. 2006;66(12):6225–32. doi:10.1158/0008-5472.CAN-06-0094.PubMedCrossRef

34.

Jacobs JJ, van Lohuizen M. Polycomb repression: from cellular memory to cellular proliferation and cancer. Biochim Biophys Acta. 2002;1602(2):151–61.PubMed

35.

Bachelder RE, Yoon SO, Franci C, de Herreros AG, Mercurio AM. Glycogen synthase kinase-3 is an endogenous inhibitor of Snail transcription: implications for the epithelial–mesenchymal transition. J Cell Biol. 2005;168(1):29–33. doi:10.1083/jcb.200409067.PubMedCentralPubMedCrossRef

36.

Zhou BP, Deng J, Xia W, Xu J, Li YM, Gunduz M, et al. Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial–mesenchymal transition. Nat Cell Biol. 2004;6(10):931–40. doi:10.1038/ncb1173.PubMedCrossRef

37.

Yamamura H, Ugawa S, Ueda T, Morita A, Shimada S. TRPM8 activation suppresses cellular viability in human melanoma. Am J Physiol Cell Physiol. 2008;295(2):C296–301. doi:10.1152/ajpcell.00499.2007.PubMedCrossRef

38.

Li Q, Wang X, Yang Z, Wang B, Li S. Menthol induces cell death via the TRPM8 channel in the human bladder cancer cell line T24. Oncology. 2009;77(6):335–41. doi:10.1159/000264627.PubMedCrossRef

39.

Bidaux G, Flourakis M, Thebault S, Zholos A, Beck B, Gkika D, et al. Prostate cell differentiation status determines transient receptor potential melastatin member 8 channel subcellular localization and function. J Clin Invest. 2007;117(6):1647–57. doi:10.1172/JCI30168.PubMedCentralPubMedCrossRef

40.

Berridge MJ, Lipp P, Bootman MD. The versatility and universality of calcium signalling. Nat Rev Mol Cell Biol. 2000;1(1):11–21. doi:10.1038/35036035.PubMedCrossRef

41.

Weber CE, Li NY, Wai PY, Kuo PC. Epithelial–mesenchymal transition, TGF-beta, and osteopontin in wound healing and tissue remodeling after injury. J Burn Care Res Off Publ Am Burn Assoc. 2012;33(3):311–8. doi:10.1097/BCR.0b013e318240541e.CrossRef

42.

Frame S, Cohen P. GSK3 takes centre stage more than 20 years after its discovery. Biochem J. 2001;359(Pt 1):1–16.PubMedCentralPubMedCrossRef

43.

Batlle E, Sancho E, Franci C, Dominguez D, Monfar M, Baulida J, et al. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol. 2000;2(2):84–9. doi:10.1038/35000034.PubMedCrossRef

44.

Katoh M. Epithelial–mesenchymal transition in gastric cancer (Review). Int J Oncol. 2005;27(6):1677–83.PubMed

45.

Roxanis I. Occurrence and significance of epithelial–mesenchymal transition in breast cancer. J Clin Pathol. 2013;66(6):517–21. doi:10.1136/jclinpath-2012-201348.PubMedCrossRef

46.

Ouadid-Ahidouch H, Ahidouch A. K⁺ channel expression in human breast cancer cells: involvement in cell cycle regulation and carcinogenesis. J Membr Biol. 2008;221(1):1–6. doi:10.1007/s00232-007-9080-6.PubMedCrossRef

47.

Potier M, Joulin V, Roger S, Besson P, Jourdan ML, Leguennec JY, et al. Identification of SK3 channel as a new mediator of breast cancer cell migration. Mol Cancer Ther. 2006;5(11):2946–53. doi:10.1158/1535-7163.MCT-06-0194.PubMedCrossRef

48.

Zhang L, Zou W, Zhou SS, Chen DD. Potassium channels and proliferation and migration of breast cancer cells. Sheng li xue bao [Acta Physiol Sin]. 2009;61(1):15–20.

49.

Fraser SP, Diss JK, Chioni AM, Mycielska ME, Pan H, Yamaci RF, et al. Voltage-gated sodium channel expression and potentiation of human breast cancer metastasis. Clin Cancer Res Off J Am Assoc Cancer Res. 2005;11(15):5381–9. doi:10.1158/1078-0432.CCR-05-0327.CrossRef

50.

Roger S, Potier M, Vandier C, Besson P, Le Guennec JY. Voltage-gated sodium channels: new targets in cancer therapy? Curr Pharm Des. 2006;12(28):3681–95.PubMedCrossRef

51.

Yang S, Zhang JJ, Huang XY. Orai1 and STIM1 are critical for breast tumor cell migration and metastasis. Cancer Cell. 2009;15(2):124–34. doi:10.1016/j.ccr.2008.12.019.PubMedCrossRef

52.

Song LB, Li J, Liao WT, Feng Y, Yu CP, Hu LJ, et al. The polycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial–mesenchymal transition in human nasopharyngeal epithelial cells. J Clin Invest. 2009;119(12):3626–36. doi:10.1172/JCI39374.PubMedCentralPubMedCrossRef

53.

Slominski A. Cooling skin cancer: menthol inhibits melanoma growth. Focus on TRPM8 activation suppresses cellular viability in human melanoma. Am J Physiol Cell Physiol. 2008;295(2):C293–5. doi:10.1152/ajpcell.00312.2008.PubMedCentralPubMedCrossRef

54.

Bai VU, Murthy S, Chinnakannu K, Muhletaler F, Tejwani S, Barrack ER, et al. Androgen regulated TRPM8 expression: a potential mRNA marker for metastatic prostate cancer detection in body fluids. Int J Oncol. 2010;36(2):443–50.PubMed

Titel: TRPM8 promotes aggressiveness of breast cancer cells by regulating EMT via activating AKT/GSK-3β pathway
verfasst von: Jinxin Liu
Yizhi Chen
Shuai Shuai
Dapeng Ding
Rong Li
Rongcheng Luo
Publikationsdatum: 01.09.2014
Verlag: Springer Netherlands
Erschienen in: Tumor Biology / Ausgabe 9/2014
Print ISSN: 1010-4283
Elektronische ISSN: 1423-0380
DOI: https://doi.org/10.1007/s13277-014-2077-8

Springer Medizin

TRPM8 promotes aggressiveness of breast cancer cells by regulating EMT via activating AKT/GSK-3β pathway

Abstract

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 9/2014

Evaluation of the seventh AJCC TNM staging system for gastric cancer: a meta-analysis of cohort studies

Diagnostic value of computed tomography scanning in differentiating malignant from benign solitary pulmonary nodules: a meta-analysis

Pituitary tumor-transforming gene 1 (PTTG1) is overexpressed in oral squamous cell carcinoma (OSCC) and promotes migration, invasion and epithelial–mesenchymal transition (EMT) in SCC15 cells

The programmed cell death 6 interacting protein insertion/deletion polymorphism is associated with non-small cell lung cancer risk in a Chinese Han population

Clinical value of serum Epstein-Barr virus DNA assay in the diagnosis of nasopharyngeal carcinoma

Aberrant promoter methylation of the SFRP1 gene may contribute to colorectal carcinogenesis: a meta-analysis

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie